Market Intelligence chevron_right Medical Care chevron_right Xerostomia (Dry Mouth Disease) Therapeutics
Global Report 2021

Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size, Status and Forecast 2024-2031

calendar_todayPublished: Dec 2021 descriptionPages: 107 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Artificial Saliva
        1.2.3 Salivary Stimulants
        1.2.4 Saliva Substitutes
        1.2.5 Drugs
        1.2.6 Salivary Pens
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Perspective (2016-2027)
    2.2 Xerostomia (Dry Mouth Disease) Therapeutics Growth Trends by Regions
        2.2.1 Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Xerostomia (Dry Mouth Disease) Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Xerostomia (Dry Mouth Disease) Therapeutics Industry Dynamic
        2.3.1 Xerostomia (Dry Mouth Disease) Therapeutics Market Trends
        2.3.2 Xerostomia (Dry Mouth Disease) Therapeutics Market Drivers
        2.3.3 Xerostomia (Dry Mouth Disease) Therapeutics Market Challenges
        2.3.4 Xerostomia (Dry Mouth Disease) Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Revenue
        3.1.1 Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Xerostomia (Dry Mouth Disease) Therapeutics Revenue
    3.4 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Concentration Ratio
        3.4.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Xerostomia (Dry Mouth Disease) Therapeutics Revenue in 2020
    3.5 Xerostomia (Dry Mouth Disease) Therapeutics Key Players Head office and Area Served
    3.6 Key Players Xerostomia (Dry Mouth Disease) Therapeutics Product Solution and Service
    3.7 Date of Enter into Xerostomia (Dry Mouth Disease) Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Xerostomia (Dry Mouth Disease) Therapeutics Breakdown Data by Type
    4.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Xerostomia (Dry Mouth Disease) Therapeutics Breakdown Data by Application
    5.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
    6.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
        6.2.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
    6.3 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
        6.3.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
    6.4 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
        6.4.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
    7.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
        7.2.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
        7.3.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
        7.4.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
    9.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
        9.2.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
        9.3.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
        9.4.1 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Acacia Pharma
        11.1.1 Acacia Pharma Company Details
        11.1.2 Acacia Pharma Business Overview
        11.1.3 Acacia Pharma Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.1.4 Acacia Pharma Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.1.5 Acacia Pharma Recent Development
    11.2 Church & Dwight
        11.2.1 Church & Dwight Company Details
        11.2.2 Church & Dwight Business Overview
        11.2.3 Church & Dwight Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.2.4 Church & Dwight Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.2.5 Church & Dwight Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.3.4 GlaxoSmithKline Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Hikma Pharmaceuticals
        11.4.1 Hikma Pharmaceuticals Company Details
        11.4.2 Hikma Pharmaceuticals Business Overview
        11.4.3 Hikma Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.4.4 Hikma Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.4.5 Hikma Pharmaceuticals Recent Development
    11.5 Lupin
        11.5.1 Lupin Company Details
        11.5.2 Lupin Business Overview
        11.5.3 Lupin Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.5.4 Lupin Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.5.5 Lupin Recent Development
    11.6 OraCoat
        11.6.1 OraCoat Company Details
        11.6.2 OraCoat Business Overview
        11.6.3 OraCoat Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.6.4 OraCoat Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.6.5 OraCoat Recent Development
    11.7 Parnell Pharmaceuticals
        11.7.1 Parnell Pharmaceuticals Company Details
        11.7.2 Parnell Pharmaceuticals Business Overview
        11.7.3 Parnell Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.7.4 Parnell Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.7.5 Parnell Pharmaceuticals Recent Development
    11.8 Pendopharm
        11.8.1 Pendopharm Company Details
        11.8.2 Pendopharm Business Overview
        11.8.3 Pendopharm Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.8.4 Pendopharm Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.8.5 Pendopharm Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.9.4 Pfizer Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 Sun Pharmaceutical Industries
        11.10.1 Sun Pharmaceutical Industries Company Details
        11.10.2 Sun Pharmaceutical Industries Business Overview
        11.10.3 Sun Pharmaceutical Industries Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.10.4 Sun Pharmaceutical Industries Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.10.5 Sun Pharmaceutical Industries Recent Development
    11.11 Synedgen
        11.11.1 Synedgen Company Details
        11.11.2 Synedgen Business Overview
        11.11.3 Synedgen Xerostomia (Dry Mouth Disease) Therapeutics Introduction
        11.11.4 Synedgen Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
        11.11.5 Synedgen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Artificial Saliva
    Table 3. Key Players of Salivary Stimulants
    Table 4. Key Players of Saliva Substitutes
    Table 5. Key Players of Drugs
    Table 6. Key Players of Salivary Pens
    Table 7. Key Players of Others
    Table 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions (2016-2021)
    Table 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions (2022-2027)
    Table 14. Xerostomia (Dry Mouth Disease) Therapeutics Market Trends
    Table 15. Xerostomia (Dry Mouth Disease) Therapeutics Market Drivers
    Table 16. Xerostomia (Dry Mouth Disease) Therapeutics Market Challenges
    Table 17. Xerostomia (Dry Mouth Disease) Therapeutics Market Restraints
    Table 18. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Players (2016-2021)
    Table 20. Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia (Dry Mouth Disease) Therapeutics as of 2020)
    Table 21. Ranking of Global Top Xerostomia (Dry Mouth Disease) Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Xerostomia (Dry Mouth Disease) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Xerostomia (Dry Mouth Disease) Therapeutics Product Solution and Service
    Table 25. Date of Enter into Xerostomia (Dry Mouth Disease) Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2016-2021)
    Table 29. Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Application (2016-2021)
    Table 33. Global Xerostomia (Dry Mouth Disease) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Acacia Pharma Company Details
    Table 66. Acacia Pharma Business Overview
    Table 67. Acacia Pharma Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 68. Acacia Pharma Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 69. Acacia Pharma Recent Development
    Table 70. Church & Dwight Company Details
    Table 71. Church & Dwight Business Overview
    Table 72. Church & Dwight Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 73. Church & Dwight Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 74. Church & Dwight Recent Development
    Table 75. GlaxoSmithKline Company Details
    Table 76. GlaxoSmithKline Business Overview
    Table 77. GlaxoSmithKline Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 78. GlaxoSmithKline Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 79. GlaxoSmithKline Recent Development
    Table 80. Hikma Pharmaceuticals Company Details
    Table 81. Hikma Pharmaceuticals Business Overview
    Table 82. Hikma Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 83. Hikma Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 84. Hikma Pharmaceuticals Recent Development
    Table 85. Lupin Company Details
    Table 86. Lupin Business Overview
    Table 87. Lupin Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 88. Lupin Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 89. Lupin Recent Development
    Table 90. OraCoat Company Details
    Table 91. OraCoat Business Overview
    Table 92. OraCoat Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 93. OraCoat Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 94. OraCoat Recent Development
    Table 95. Parnell Pharmaceuticals Company Details
    Table 96. Parnell Pharmaceuticals Business Overview
    Table 97. Parnell Pharmaceuticals Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 98. Parnell Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 99. Parnell Pharmaceuticals Recent Development
    Table 100. Pendopharm Company Details
    Table 101. Pendopharm Business Overview
    Table 102. Pendopharm Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 103. Pendopharm Recent Development
    Table 104. Pfizer Company Details
    Table 105. Pfizer Business Overview
    Table 106. Pfizer Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 107. Pfizer Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 108. Pfizer Recent Development
    Table 109. Sun Pharmaceutical Industries Company Details
    Table 110. Sun Pharmaceutical Industries Business Overview
    Table 111. Sun Pharmaceutical Industries Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 112. Sun Pharmaceutical Industries Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 113. Sun Pharmaceutical Industries Recent Development
    Table 114. Synedgen Company Details
    Table 115. Synedgen Business Overview
    Table 116. Synedgen Xerostomia (Dry Mouth Disease) Therapeutics Product
    Table 117. Synedgen Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021) & (US$ Million)
    Table 118. Synedgen Recent Development
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Artificial Saliva Features
    Figure 3. Salivary Stimulants Features
    Figure 4. Saliva Substitutes Features
    Figure 5. Drugs Features
    Figure 6. Salivary Pens Features
    Figure 7. Others Features
    Figure 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application: 2020 VS 2027
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Hospital Pharmacies Case Studies
    Figure 11. Online Pharmacies Case Studies
    Figure 12. Xerostomia (Dry Mouth Disease) Therapeutics Report Years Considered
    Figure 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 16. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions (2022-2027)
    Figure 17. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Players in 2020
    Figure 18. Global Top Xerostomia (Dry Mouth Disease) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia (Dry Mouth Disease) Therapeutics as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Xerostomia (Dry Mouth Disease) Therapeutics Revenue in 2020
    Figure 20. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 21. Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 22. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
    Figure 24. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
    Figure 25. North America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
    Figure 26. United States Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
    Figure 30. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
    Figure 31. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
    Figure 32. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Region (2016-2027)
    Figure 42. China Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
    Figure 50. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
    Figure 51. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
    Figure 52. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Country (2016-2027)
    Figure 58. Turkey Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Xerostomia (Dry Mouth Disease) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Acacia Pharma Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 62. Church & Dwight Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 63. GlaxoSmithKline Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 64. Hikma Pharmaceuticals Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 65. Lupin Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 66. OraCoat Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 67. Parnell Pharmaceuticals Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 68. Pendopharm Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 69. Pfizer Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 70. Sun Pharmaceutical Industries Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 71. Synedgen Revenue Growth Rate in Xerostomia (Dry Mouth Disease) Therapeutics Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Acacia Pharma
Church & Dwight
GlaxoSmithKline
Hikma Pharmaceuticals
Lupin
OraCoat
Parnell Pharmaceuticals
Pendopharm
Pfizer
Sun Pharmaceutical Industries
Synedgen

Frequently Asked Questions

What is the USP of the report? expand_more
Xerostomia (Dry Mouth Disease) Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Xerostomia (Dry Mouth Disease) Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Xerostomia (Dry Mouth Disease) Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.